In order to determine whether FGL1 positive circulating tumor cells is an independent risk factor affecting the patient’s prognosis, we used the propensity score matching method to avoid confounding factors including age, gender, hepatitis B virus infection, AFP level, tumor number, tumor diameter, lymph node metastasis, TNM stage and distant metastasis. This evidence concerns the gene AFP and hepatitis B virus infection.